
Please try another search
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was founded in 1997 and is based in Xi'an, China.
Name | Age | Since | Title |
---|---|---|---|
Qingshui Luo | 63 | - | Chairman of the Supervisory Board & Director of Legal Department |
Xiaolin Xie | 56 | - | GM & Chairman |
Wenfeng Zhu | 54 | 2022 | Shareholder Supervisor |
Xiaofeng Xie | 48 | 2013 | Non-Independent Director |
Jie Wu | 54 | - | Deputy GM, Board Secretary & Director |
Zhihong Zhang | 60 | - | Deputy GM & Director |
Haiyun Ren | 50 | 2019 | Independent Director |
Dezhu Zhang | 48 | 2023 | Deputy & GM Director |
Leipeng Jiao | 41 | 2019 | Independent Director |
Hui Ma | 41 | 2022 | Shareholder Supervisor |
Zhekun Chen | 42 | - | Supervisor |
Tailin Xiong | 48 | 2022 | Employee Representative Supervisor |
Xiaofeng Niu | 58 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review